Home › Prostate Cancer › Mississippi › Jackson
Prostate Cancer clinical trials in Jackson, MS
5 studies for Prostate Cancer are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- University of Mississippi Medical Center, Jackson
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- University of Mississippi Medical Center, Jackson
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RecruitingPhase 4
- University of Mississippi Med Ctr, Jackson
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RecruitingObservational study
- University of Mississippi Medical Center, Jackson
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RecruitingPhase 3
- University of Mississippi Medical Center, Jackson
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA60 studies
- St. Louis, MO47 studies
- San Francisco, CA45 studies
- Chicago, IL45 studies
- Seattle, WA44 studies
- Philadelphia, PA44 studies
- Nashville, TN43 studies
- Baltimore, MD42 studies
- Washington, DC38 studies
Other studies in Jackson
- Obesity8 studies
- Overweight6 studies
- Breast Cancer5 studies
- Heart Failure5 studies
- Sickle Cell Disease5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Steatotic Liver Disease5 studies
- Type 2 Diabetes5 studies
- Attention Deficit Hyperactivity Disorder4 studies
- Burkitt Lymphoma4 studies
- Migraine4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.